A phase I clinical and pharmacokinetic study of brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule
Authors:
- S. VestSVS. Vest
- H.H. HansenHHH.H. Hansen
- 1 October 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (10) , 1403-1411
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I studyEuropean Journal of Cancer and Clinical Oncology, 1989
- Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390)Investigational New Drugs, 1987
- EORTC guidelines for phase I trials with single agents in adultsEuropean Journal of Cancer and Clinical Oncology, 1985
- The Variability of Individual Tolerance to Methotrexate in Cancer PatientsBritish Journal of Cancer, 1971